The Salivary Microbiome in Children With Type 1 Diabetes Mellitus
The study conducted by Hadassah Medical Organization aims to elucidate the differences in the salivary microbiome between children with Type 1 Diabetes Mellitus (T1DM) and healthy controls. This research could have significant implications for understanding the oral health challenges faced by diabetic children, potentially leading to new diagnostic tools or therapeutic strategies. The market for diabetes management and related oral health products is substantial, with increasing awareness of the microbiome's role in health. Competitively, this study may position Hadassah as a leader in microbiome research related to diabetes, attracting partnerships or funding opportunities. Diligence implications include the need for further studies to validate findings and explore commercial applications.
Indication: Type1 Diabetes Mellitus
Modality: RNA therapy
Target: Salivary microbiome profile related to oral health in children with Type 1 Diabetes Mellitus.
Sponsor: Hadassah Medical Organization
Source URL: ClinicalTrials.gov
Source updated: Detailed source ingestion pending
Ingested: Jul 21, 2026
Model: trialsignal-ai-v1
Validation: validated
Matched by target_normalized: Salivary microbiome profile related to oral health in children with Type 1 Diabetes Mellitus.
View original source fields
Condition raw: Type1 Diabetes Mellitus
Condition normalized: Type1 Diabetes Mellitus
Modality raw: RNA therapy
Modality normalized: RNA therapy
Target raw: Salivary microbiome profile related to oral health in children with Type 1 Diabetes Mellitus.
Target normalized: Salivary microbiome profile related to oral health in children with Type 1 Diabetes Mellitus.